These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6307775)

  • 1. Prevalence of neutralizing antibodies against a candidate rotavirus vaccine in adults.
    Zissis G; Marissens D; Lambert JP; Marbehant P
    Dev Biol Stand; 1983; 53():201-8. PubMed ID: 6307775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response of pregnant cows to bovine rotavirus immunization.
    Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
    Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic background for the need of rotavirus vaccine in Finland. Preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults.
    Vesikari T; Mäki M; Isolauri E
    Dev Biol Stand; 1983; 53():229-36. PubMed ID: 6307778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.
    Ward RL; Kirkwood CD; Sander DS; Smith VE; Shao M; Bean JA; Sack DA; Bernstein DI
    J Infect Dis; 2006 Dec; 194(12):1729-36. PubMed ID: 17109346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus serotype-specific neutralizing activity in human milk.
    Bell LM; Clark HF; Offit PA; Slight PH; Arbeter AM; Plotkin SA
    Am J Dis Child; 1988 Mar; 142(3):275-8. PubMed ID: 2830785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge.
    Zissis G; Lambert JP; Marbehant P; Marissens D; Lobmann M; Charlier P; Delem A; Zygraich N
    J Infect Dis; 1983 Dec; 148(6):1061-8. PubMed ID: 6317767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
    Iosef C; Chang KO; Azevedo MS; Saif LJ
    J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets.
    Wang Y; Azevedo M; Saif LJ; Gentsch JR; Glass RI; Jiang B
    Vaccine; 2010 Jul; 28(33):5432-6. PubMed ID: 20558244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rotaviruses in human and veterinary medicine].
    Dodet B; Heseltine E; Mary C; Saliou P
    Sante; 1997; 7(3):195-9. PubMed ID: 9296811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of neutralizing antibodies to animal rotavirus strains and human rotavirus serotype G8 by a modified method in the residents of Pune, India.
    Kelkar SD; Ray PG; Bedekar SS
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):101-6. PubMed ID: 8870403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.
    Powell DG; Dwyer RM; Traub-Dargatz JL; Fulker RH; Whalen JW; Srinivasappa J; Acree WM; Chu HJ
    J Am Vet Med Assoc; 1997 Jul; 211(2):193-8. PubMed ID: 9227750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of neutralizing antibody to the calf rotavirus in New York cattle.
    Schlafer DH; Scott FW
    Cornell Vet; 1979 Jul; 69(3):262-71. PubMed ID: 225124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity.
    Asensi MT; Martínez-Costa C; Buesa J
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):560-7. PubMed ID: 16707981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus.
    McNeal MM; Ward RL
    Virology; 1995 Aug; 211(2):474-80. PubMed ID: 7645251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus infection in Otago: a serological study.
    Holdaway MD; Kalmakoff J; Schroeder BA; Wright GC; Todd BA; Jennings LC
    N Z Med J; 1982 Feb; 95(702):110-2. PubMed ID: 6281701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies to rotavirus in human milk (author's transl)].
    Maass G; Barckhaus C
    Zentralbl Bakteriol A; 1980 Mar; 246(3):294-303. PubMed ID: 6252721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.